Nearly 10,000 participants are in Istanbul at  the congress of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) to share their knowledge and discuss the latest research findings. New pioneering studies have been presented: 

- Gupta, A et al. "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" 

By SFP-iron administration, the ESA dose could be reduced by 35% while maintaining stable Hb levels. There were no SFP-related adverse effects and no cases of iron overload.

 - Van Eps, C. "THE EFFECTS OF TOPICAL ANTIBACTERIAL HONEY ON CATHETER-RELATED INFECTIONS IN PERITONEAL DIALYSISPATIENTS " 

Extended use of the common antibiotic azithromycin may prolong the time between hospitalizations for patients suffering from chronic obstructive pulmonary disease (COPD), according to a post-hoc analysis of a multicenter study which compared the hospitalization rates of patients treated with a 12-month course of azithromycin to the rates of those treated with placebo. 

Yesterday, a monster tornado almost 2-miles wide tore through Moore, Oklahoma, a suburb of Oklahoma City, wiping out entire blocks and killing 24 people. 

The National Weather Service upgraded its calculation of the storm's strength today, declaring it was a rare EF5, the most powerful ranking on the Enhanced Fujita Scale, and had winds exceeding 200 miles per hour and left a trail of destruction measuring about 17 miles long. Debris from the tornado fell as far as 100 miles away, reaching the city of Tulsa.

Proteins may be more of a factor in shaping regulatory patterns than environment, according to a new study that looks at how cells' protein networks relate to a bacteria's genome.

The lab of computer scientist Luay Nakhleh ar Rice University reported in the Proceedings of the National Academy of Sciences that when environmental factors are eliminated from an evolutionary model, mutations and genetic drift can give rise to the patterns that appear. They studied changes that show up in regulatory networks that determine the organism's characteristics.

A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers.

The randomized, double-blind, placebo-controlled trial tested the efficacy and safety of the monoclonal antibody, dupilumab, in patients with "persistent, moderate-to-severe asthma" and elevated eosinophils, which are immune cells that mobilize in response to allergens and infections and are commonly seen in asthma.

Dupilumab, a fully human monoclonal antibody discovered by Regeneron Pharmaceuticals and being developed by Regeneron and Sanofi, thwarts activation of the Th2 immune response implicated in asthma by blocking two cytokines, interleukin-4 and interleukin-13.

A new analysis shows that America could produce almost 9% of its annual energy needs -  25 billion gallons of fuel - using algae.

But it will take a lot of water.

Algae are plump with oil and various research teams and companies are pursuing ways to improve the creation of biofuels based on algae – growing algae composed of more oil, creating algae that live longer and thrive in cooler temperatures, or devising new ways to separate out the useful oil from the rest of the algae.